NEUROFIBROMATOSIS TYPE 2
Clinical trials for NEUROFIBROMATOSIS TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS TYPE 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial halted for rare brain tumor condition
Disease control TerminatedThis study tested an investigational drug called REC-2282 to see if it could slow or stop the growth of brain tumors (meningiomas) in people with Neurofibromatosis Type 2 (NF2). It involved about 25 participants aged 12 and older with progressive tumors. The trial was designed in…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE2, PHASE3 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test new Drug's reach into Hard-to-Treat brain tumors
Knowledge-focused TerminatedThis early study tested whether an experimental drug called AR-42 could reach two types of brain and nerve tumors and affect a specific protein linked to cancer growth. A small group of adults scheduled for tumor removal surgery took the drug for three weeks before their operatio…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: EARLY_PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC